Astronomers are baffled by EP240408a, a rare cosmic explosion that defies explanation, sparking theories of a black hole and ...

Basel: Novartis today announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, ...

ISRO confirms SpaDeX docking completed without issues Orbit raising stalled due to oxidiser valve malfunction Future experiments planned to enhance docking tech ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody ...

Swiss pharmaceutical firm Novartis said on Tuesday that it has agreed to buy privately held, clinical-stage US biotech Anthos ...

The transaction, expected to close in the first half of this year, will cost Novartis $925 million upfront with potential ...

Anthos is currently conducting a phase 3 clinical study in patients with atrial fibrillation with high risk for stroke or systemic embolism (LILAC-TIMI 76) as well as two phase 3 studies in patients ...

Novartis AG has agreed to acquire Anthos Therapeutics for $925 million as the European drug giant seeks to bolster its ...

Ads from Anheuser-Busch attracted acclaim to the beer-maker's marketing pitches on a day of star-studded—and expensive—advertisements.

ISRO tests CE20 cryogenic engine under vacuum conditions The test advances engine restart capabilities for LVM-3 CE20 engine ...